Work

Reasons for Initiation of First-Line Therapy and Early Outcomes for Patients (Pts) with Rai 0/1 Chronic Lymphocytic Leukemia (CLL): An Analysis of the Connect CLL® Cohort Study

Year: 2015

Type: article

Source: Blood

DOI: 10.1182/blood.v126.23.3284.3284

Authors: Christopher Flowers, Chadi Nabhan, Neil E. Kay, Anthony Mato, Nicole Lamanna, David L. Grinblatt, Thomas J. Kipps, Mark Kozloff, Kristen Sullivan, E. Dawn Flick, Pavel Kiselev, Shriya Bhushan, Arlene S. Swern, Jeff P. Sharman

Institutions: Winship Cancer Institute, University of Chicago, Mayo Clinic, Abramson Cancer Center, University of Pennsylvania, Columbia University Irving Medical Center, Endeavor Health, University of California San Diego, Moores Cancer Center, Ingalls Memorial Hospital, Celgene (United States), Willamette Valley Cancer Institute and Research Center

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2554714239

FWCI:

Cites:

Cited by:

Related to: 10